In ovalbumin induced asthma animal model, IL-22 neutralization with mAbs during sensitization stage of disease, which is similar to the pulmonary fibrosis research just mentioned above, evidently alleviated lung pathology and airway inflammation. This evidence concerns the gene IL22 and asthma.